FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2345485155> ?p ?o ?g. }

• W2345485155 endingPage "1136045" @default.
• W2345485155 startingPage "1136045" @default.
• W2345485155 abstract "Purpose: Therapy targeting CTLA-4 immune checkpoint provides increased survival in patients with advanced melanoma. However, immunotherapy is frequently associated with delayed and heterogeneous clinical responses and it is important to identify prognostic immunological correlates of clinical endpoints. Experimental design: 77 patients with stage III/IV melanoma were treated with ipilimumab alone every 3 weeks, during 9 weeks. Blood samples were collected at the baseline and before each dose for in depth immune monitoring. Results: The median follow-up was 28 mo with a median survival of 7 mo. Survival and clinical benefit were significantly improved when absolute lymphocyte count at the baseline was above 1 × 109/L. Notably, ipilimumab had a global effect on memory T cells, with an early increase of central and effector subsets in patients with disease control. By contrast, percentages of stem cell memory T cells (TSCM) gradually decreased despite stable absolute counts and sustained proliferation, suggesting a process of differentiation. Higher proportions of eomes+ and Ki-67+ T cells were observed, with enhanced skin homing potential and induction of cytotoxic markers. Conclusion: These results suggest that CTLA-4 blockade is able to reshape the memory subset with the potential involvement of Eomes and memory subsets including TSCM." @default.
• W2345485155 created "2016-06-24" @default.
• W2345485155 creator A5000888675 @default.
• W2345485155 creator A5017428353 @default.
• W2345485155 creator A5022002813 @default.
• W2345485155 creator A5023541726 @default.
• W2345485155 creator A5025478490 @default.
• W2345485155 creator A5025658993 @default.
• W2345485155 creator A5038884673 @default.
• W2345485155 creator A5040819465 @default.
• W2345485155 creator A5047625349 @default.
• W2345485155 creator A5050755416 @default.
• W2345485155 creator A5063292795 @default.
• W2345485155 creator A5066493529 @default.
• W2345485155 creator A5066653250 @default.
• W2345485155 creator A5068469347 @default.
• W2345485155 creator A5068479125 @default.
• W2345485155 creator A5075919552 @default.
• W2345485155 date "2016-02-18" @default.
• W2345485155 modified "2023-10-17" @default.
• W2345485155 title "Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response" @default.
• W2345485155 cites W1524533358 @default.
• W2345485155 cites W1541193052 @default.
• W2345485155 cites W1572743872 @default.
• W2345485155 cites W1661441964 @default.
• W2345485155 cites W1823658262 @default.
• W2345485155 cites W1849671624 @default.
• W2345485155 cites W1965215390 @default.
• W2345485155 cites W1967084952 @default.
• W2345485155 cites W1971613814 @default.
• W2345485155 cites W1974208182 @default.
• W2345485155 cites W1976785514 @default.
• W2345485155 cites W1978373343 @default.
• W2345485155 cites W1981528932 @default.
• W2345485155 cites W1982005697 @default.
• W2345485155 cites W1989976028 @default.
• W2345485155 cites W2002566731 @default.
• W2345485155 cites W2009253992 @default.
• W2345485155 cites W2014545440 @default.
• W2345485155 cites W2043793366 @default.
• W2345485155 cites W2048073154 @default.
• W2345485155 cites W2052834898 @default.
• W2345485155 cites W2054535181 @default.
• W2345485155 cites W2058160830 @default.
• W2345485155 cites W2076087586 @default.
• W2345485155 cites W2080442133 @default.
• W2345485155 cites W2082158071 @default.
• W2345485155 cites W2082450021 @default.
• W2345485155 cites W2084544484 @default.
• W2345485155 cites W2094366129 @default.
• W2345485155 cites W2097437224 @default.
• W2345485155 cites W2097995306 @default.
• W2345485155 cites W2103019838 @default.
• W2345485155 cites W2107863654 @default.
• W2345485155 cites W2109465910 @default.
• W2345485155 cites W2111836805 @default.
• W2345485155 cites W2114738239 @default.
• W2345485155 cites W2118503880 @default.
• W2345485155 cites W2118863192 @default.
• W2345485155 cites W2119319172 @default.
• W2345485155 cites W2120622246 @default.
• W2345485155 cites W2123363005 @default.
• W2345485155 cites W2128758225 @default.
• W2345485155 cites W2133075384 @default.
• W2345485155 cites W2134638467 @default.
• W2345485155 cites W2136896422 @default.
• W2345485155 cites W2143467222 @default.
• W2345485155 cites W2144796561 @default.
• W2345485155 cites W2144995154 @default.
• W2345485155 cites W2149748445 @default.
• W2345485155 cites W2150213518 @default.
• W2345485155 cites W2155104279 @default.
• W2345485155 cites W2166226087 @default.
• W2345485155 cites W2166626276 @default.
• W2345485155 cites W2166662937 @default.
• W2345485155 cites W2171026458 @default.
• W2345485155 cites W2335365056 @default.
• W2345485155 doi "https://doi.org/10.1080/2162402x.2015.1136045" @default.
• W2345485155 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5006913" @default.
• W2345485155 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27622012" @default.
• W2345485155 hasPublicationYear "2016" @default.
• W2345485155 type Work @default.
• W2345485155 sameAs 2345485155 @default.
• W2345485155 citedByCount "21" @default.
• W2345485155 countsByYear W23454851552016 @default.
• W2345485155 countsByYear W23454851552017 @default.
• W2345485155 countsByYear W23454851552018 @default.
• W2345485155 countsByYear W23454851552019 @default.
• W2345485155 countsByYear W23454851552020 @default.
• W2345485155 countsByYear W23454851552021 @default.
• W2345485155 countsByYear W23454851552023 @default.
• W2345485155 crossrefType "journal-article" @default.
• W2345485155 hasAuthorship W2345485155A5000888675 @default.
• W2345485155 hasAuthorship W2345485155A5017428353 @default.
• W2345485155 hasAuthorship W2345485155A5022002813 @default.
• W2345485155 hasAuthorship W2345485155A5023541726 @default.
• W2345485155 hasAuthorship W2345485155A5025478490 @default.
• W2345485155 hasAuthorship W2345485155A5025658993 @default.

• next